Posters
Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)
March 3, 2026
More infoPosters
Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity
March 3, 2026
More infoPosters
Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry
March 3, 2026
More infoWeb News
CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI
March 3, 2026
More infoNews
Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement
February 3, 2026
More infoCellTalk Blog
How to Select the Optimal TBNK Panel: Matching Immune Monitoring to Clinical Context
November 25, 2025
Immune Monitoring
More infoCellTalk Blog
This is SPARTA: A Framework for Multiplex Immunofluorescence Analysis
November 13, 2025
More infoPosters
Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
November 10, 2025
Proteomics/Mass Spectrometry
More infoCellTalk Blog
Improving RNA-Seq Library Preparation with the Watchmaker Workflow
November 5, 2025
Genomics
More info